BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16619505)

  • 1. Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
    Zhai G; Wu J; Xiang G; Mao W; Yu B; Li H; Piao L; Lee LJ; Lee RJ
    J Nanosci Nanotechnol; 2009 Mar; 9(3):2155-61. PubMed ID: 19435095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes
    Wen T; Gao Y; Zheng Y; Shan B; Song C; An Y; Cui J
    Curr Pharm Biotechnol; 2024; 25(4):510-519. PubMed ID: 37957921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Clickable" polymer-caged nanobins as a modular drug delivery platform.
    Lee SM; Chen H; O'Halloran TV; Nguyen ST
    J Am Chem Soc; 2009 Jul; 131(26):9311-20. PubMed ID: 19527027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions.
    Antony A; Tang YS; Khan RA; Biju MP; Xiao X; Li QJ; Sun XL; Jayaram HN; Stabler SP
    J Clin Invest; 2004 Jan; 113(2):285-301. PubMed ID: 14722620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery.
    Yang S; Yang X; Liu Y; Zheng B; Meng L; Lee RJ; Xie J; Teng L
    Colloids Surf B Biointerfaces; 2015 Nov; 135():274-282. PubMed ID: 26263216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery and enhanced gene-silencing activity of centrally modified folic acid-siRNA conjugates.
    Salim L; Islam G; Desaulniers JP
    Nucleic Acids Res; 2020 Jan; 48(1):75-85. PubMed ID: 31777918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanoparticles enhanced flow electroporation of antisense oligonucleotides in leukemia cells.
    Wang S; Zhang X; Yu B; Lee RJ; Lee LJ
    Biosens Bioelectron; 2010 Oct; 26(2):778-83. PubMed ID: 20630739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data for stable formulation of steroid hormone receptor-targeted liposomes for cancer therapeutics.
    Sharma P; Banerjee R; Narayan KP
    Data Brief; 2016 Jun; 7():428-31. PubMed ID: 27006974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia.
    Yang Z; Yu B; Zhu J; Huang X; Xie J; Xu S; Yang X; Wang X; Yung BC; Lee LJ; Lee RJ; Teng L
    Nanoscale; 2014 Aug; 6(16):9742-51. PubMed ID: 25003978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.
    Dhule SS; Penfornis P; He J; Harris MR; Terry T; John V; Pochampally R
    Mol Pharm; 2014 Feb; 11(2):417-27. PubMed ID: 24380633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.
    Gomes-da-Silva LC; Simões S; Moreira JN
    Cell Mol Life Sci; 2014 Apr; 71(8):1417-38. PubMed ID: 24221135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-based therapeutics for the treatment of human B cell malignancies.
    Baskar S; Muthusamy N
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):33-43. PubMed ID: 23229130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery.
    Wang R; Xiao R; Zeng Z; Xu L; Wang J
    Int J Nanomedicine; 2012; 7():4185-98. PubMed ID: 22904628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of calf thymus DNA to tumor by folate receptor targeted cationic liposomes.
    Li H; Piao L; Yu B; Yung BC; Zhang W; Wang PG; Lee JL; Lee RJ
    Biomaterials; 2011 Sep; 32(27):6614-20. PubMed ID: 21665267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of G3139 lipid nanoparticles (LNPs).
    Pan X; Chen L; Liu S; Yang X; Gao JX; Lee RJ
    Mol Pharm; 2009; 6(1):211-20. PubMed ID: 19072654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Plk1 expression by receptor-mediated uptake of antisense oligonucleotide-loaded nanoparticles.
    Spänkuch B; Steinhauser I; Wartlick H; Kurunci-Csacsko E; Strebhardt KI; Langer K
    Neoplasia; 2008 Mar; 10(3):223-34. PubMed ID: 18320067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanovehicular intracellular delivery systems.
    Prokop A; Davidson JM
    J Pharm Sci; 2008 Sep; 97(9):3518-90. PubMed ID: 18200527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes.
    Chiu SJ; Liu S; Perrotti D; Marcucci G; Lee RJ
    J Control Release; 2006 May; 112(2):199-207. PubMed ID: 16564596
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.